Back
Protagonist Therapeutics Vs. TransMedics Group Industry Stock Comparison
Buy
71
PTGX
Protagonist Therapeutics
Last Price:
30.74
Seasonality Move:
16.08%
Buy
69
TMDX
TransMedics Group
Last Price:
137.97
Seasonality Move:
23.08%
Buy
71
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $30.74. The Score for PTGX is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
69
TransMedics Group (TMDX)
is a Buy
Is TransMedics Group a Buy, Sell or Hold?
- The current TransMedics Group [TMDX] share price is $137.98. The Score for TMDX is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- TMDX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $30.74
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.
TMDX Stock Price Chart
What is TransMedics Group's stock price today?
-
The TransMedics Group share price today is $137.98
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TMDX is experiencing slight buying pressure.
PTGX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.01 | Buy |
Relative Strength Index (14 RSI): | 65.8 | Buy |
Chaikin Money Flow: | -378836 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.92 - 29.04) | Buy |
Bollinger Bands (100): | (24.71 - 29.41) | Buy |
TMDX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 12.6 | Buy |
Relative Strength Index (14 RSI): | 78.39 | Buy |
Chaikin Money Flow: | 182066 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (90.58 - 131.24) | Buy |
Bollinger Bands (100): | (72.97 - 106.43) | Buy |
PTGX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.59 | Buy |
20-day SMA: | 27.27 | Buy |
50-day SMA: | 27.76 | Buy |
200-day SMA: | 22.41 | Buy |
8-day EMA: | 29.73 | Buy |
20-day EMA: | 28.24 | Buy |
50-day EMA: | 27.54 | Buy |
200-day EMA: | 24.11 | Buy |
TMDX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 132.44 | Buy |
20-day SMA: | 116.41 | Buy |
50-day SMA: | 95.38 | Buy |
200-day SMA: | 75.27 | Buy |
8-day EMA: | 131.98 | Buy |
20-day EMA: | 119.9 | Buy |
50-day EMA: | 103.49 | Buy |
200-day EMA: | 82.58 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $2.69 per share, an increase this year of $3.70 per share, and a decrease next year of $1.31 per share.
TransMedics Group Earnings Growth & TMDX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.15 per share, an increase this year of $1.17 per share, and an increase next year of $0.16 per share.
Protagonist Therapeutics Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
TransMedics Group Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |